CTRI Number |
CTRI/2017/08/009528 [Registered on: 29/08/2017] Trial Registered Retrospectively |
Last Modified On: |
02/09/2017 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
Clinical study of MAR/HO-2 oil in mild to moderate Hair loss in females |
Scientific Title of Study
|
A single Arm, Multicenter, Prospective, Clinical study to evaluate efficacy and safety of MAR/HO-2 oil in mild to moderate Hair loss in females |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
MAR/02/2015, Version 1.0,Dated 02 Sep 2015 |
Protocol Number |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Rajashree Kulkarni |
Designation |
Ayurvedic Consultant |
Affiliation |
Ayushree Ayurvedic Hospital and Research center |
Address |
OPD No. 1, Ground Floor, OPD Department, Ayushree Ayurvedic Hospital and Research center
Parabnagar, Indira Nagar
Nashik
Nashik MAHARASHTRA 422006 India |
Phone |
9822537666 |
Fax |
|
Email |
drrajashree@ayushree.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Sanjay Tamoli |
Designation |
Director |
Affiliation |
Target Institute of Medical Education and Research |
Address |
Target Institute of Medical Education and Research
Ground Floor Office No. 1, 205 B Wing Blue Diamond Society Nayagoan Dahisar West Mumbai
Mumbai (Suburban) MAHARASHTRA 400068 India |
Phone |
9322522252 |
Fax |
|
Email |
targetinstitute@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Dr Sanjay Tamoli |
Designation |
Director |
Affiliation |
Target Institute of Medical Education and Research |
Address |
Target Institute of Medical Education and Research
Ground Floor Office No. 1, 205 B Wing Blue Diamond Society Nayagoan Dahisar West Mumbai
Mumbai (Suburban) MAHARASHTRA 400068 India |
Phone |
9322522252 |
Fax |
|
Email |
targetinstitute@yahoo.com |
|
Source of Monetary or Material Support
|
Marico Ltd. Plot No: 23/C, Mahal Industrial Estate,
Near Ahura Centre, Paper Box Gali, Mahakali Caves Road, Andheri (E), Mumbai-400093 |
|
Primary Sponsor
|
Name |
Marico Ltd |
Address |
Plot No: 23/C, Mahal Industrial Estate,
Near Ahura Centre, Paper Box Gali, Mahakali Caves Road, Andheri (E), Mumbai-400093 |
Type of Sponsor |
Pharmaceutical industry-Indian |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 2 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Rajashree Kulkarni |
Ayushree Ayurvedic Hospital and Research Center |
OPD No. 1, Ground Floor, OPD Department, Ayushree Ayurvedic Hospital and Research center
Parabnagar, Indira Nagar
Nashik
Nashik MAHARASHTRA |
9822537666
drrajashree@ayushree.com |
Dr Sachin Agiwal |
Shri Gurudeo Ayurved College and Hospital |
OPD No 28, Ground Floor, Department of Swasthrakshan Akhil Bharatiya Shri Gurudeo Sevamandal
Shri Gurudeo Ayurved College and Hospital Gurukunj Ashram Tal Tiosa Dist Amravati Amravati MAHARASHTRA |
9421829197
sachin.agiwal@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 2 |
Name of Committee |
Approval Status |
Ayushree Ayurvedic Hospital Ethics Committee Nashik |
Approved |
Institutional Ethics Committee, Akhil Bharatiya Shri Gurudeo Sevamandal, Shri Gurudeo Ayurved College, Gurukunj Amravati |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Hair loss in females, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
MAR/HO-02 Oil |
MAR/HO-02 Oil Contains Amla (Emblica officinalis), Mehandi (Lawsania ineris), Methi (Trigonella foenum graecum), Kumari (Aloe vera), Musta (Cyperus rotundus) processed in Coconut oil.
Dosage and Treatment Duration: Subjects will be asked to apply approximately 5-10 ml of hair oil every day for 60 days.
|
Comparator Agent |
NIL |
NIL |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
40.00 Year(s) |
Gender |
Female |
Details |
1.Subjects suffering from mild to moderate hair loss (by comb test).
2. Subjects who are infrequent hair oil users
3. Subjects who are willing to give informed consent and ready to comply with the protocol
4. Subjects who are ready to provide regular follow ups till the completion of the study
|
|
ExclusionCriteria |
Details |
1. Subjects with severe Hair fall due to any clinically significant disorders like anemia, thyroid disorders etc.
2. Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation
3. Subjects with recent disease history like, malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study
4. Subjects who have regularly used anti-hair fall treatment with hair oils over the last 6 months.
5. Subjects who have previously undergone hair transplantation procedures
6. Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
7. Subjects on immunosuppressive drugs
8. Known cases of Hypersensitivity to hair oil contents
9. Subjects who have participated in any other clinical study since last 3 months
10. Subjects who are reported pregnant or planning a pregnancy or lactating.
11. Menopausal Women |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Assessment of efficacy of MAR/HO-02 oil in mild to moderate hair loss in females (by running finger test and comb test)
|
Day -5, Day 0, Day 15, Day 30, Day 45 and Day 60
|
|
Secondary Outcome
|
Outcome |
TimePoints |
1.Assessment of effect of MAR/HO-02 on quality of hair based on subject questionnaire including effect on dandruff, greying and hair growth.
2.Global assessment of overall change in hair loss by the physician
3.Global assessment of overall change in hair loss by the subject
4.Assessment of safety by observing episodes, severity and duration of any allergic reactions and adverse events |
Day -5, Day 0, Day 15, Day 30, Day 45 and Day 60 |
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "51"
Final Enrollment numbers achieved (India)="51" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
19/10/2015 |
Date of Study Completion (India) |
24/03/2016 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Not Done |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This
is a single Arm, Multicenter, Prospective, Clinical study to evaluate efficacy
and safety of MAR/HO-2 oil in mild to moderate Hair loss in females. The study
will be conducted in 50 female subjects. The study will be conducted at 2
centers in India. Subjects will be asked to apply approximately 5-10 ml of
MAR/HO-2 hair oil every day for 60 days. The primary outcome will be to assess
efficacy of MAR/HO-02 oil in mild to moderate hair loss in females by running
finger test and comb test. (Day -5, Day 0, Day 15, Day 30, Day 45 and Day 60).
The secondary outcomes will be to assess effect of MAR/HO-02 on quality of hair
based on subject questionnaire including effect on dandruff, greying and hair
growth, global assessment of overall change in hair loss by physician and by subject
and safety by observing episodes, severity and duration of any allergic
reactions and adverse events (Day -5, Day 0, Day 15, Day 30, Day 45 and Day 60) |